Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Powell Industries (POWL) Price & Performance

Cassava Sciences IncTrade
Powell IndustriesTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Powell Industries — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Powell Industries trades at $196.15 (market cap $7.21B). The key difference: Powell Industries is far larger — about 183× Cassava Sciences Inc's market cap, and Powell Industries pays a 0.18% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Powell Industries for 4 Days on average.

FLNAPOWL
Market Cap
$39.40M$7.21B
Volume
759,018546,028
Sector
HealthIndustrials
52-Week High
$4.64$322.05
52-Week Low
$0.68$94.02
Typical Hold Time
37 Days4 Days
Enterprise Value
-$43.28M$6.58B
Dividend Yield
—0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.8136, down 7.01% today, with a bearish technical signal from moving averages. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent FDA approval to lift the clinical hold on simufilam for epilepsy research provides a positive catalyst, with patient screening expected by Q1 2027.

Despite operational losses and negative cash flow, analyst consensus is bullish with 8 buy ratings versus 4 hold. The key investment opportunity lies in the clinical progress of simufilam, while risks include sustained cash burn and reliance on successful drug development outcomes in a competitive biotech landscape.

Powell Industries

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNA
73% Buy27% Sell
Avg holding period · 37 Days
POWL

No sentiment data available yet.

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →

About Powell Industries

Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.

Read more on POWL →